View Cart (0 items)

Items Tagged with 'ranbaxy'


FDA's action against Ranbaxy will cost US consumers

Indian drug-maker Ranbaxy Laboratories Ltd. was supposed to introduce three generic versions of branded products that could potentially save Americans millions of dollars, but problems related to regulation and manufacturing standards are delaying their launch.
Read More

US, Indian officials meet to discuss drug safety

India and the United States have been locked in a regulatory conflict over generic pharmaceutical products distributed on the U.S. market.
Read More

Another Ranbaxy facility lands on FDA blacklist

The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More